Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations.

Hongyue QinJiaojiao KeShuai DongHuani LiKunli ZhuShuai FuQian ShaoZhenxiang Li

Published in: BMC cancer (2022)

For the patients with advanced EGFR-mutant lung adenocarcinoma, the radical thoracic radiotherapy dose scheme (≥ 60 Gy) could significantly prolong the OS of patients during the whole course management.

Keyphrases

small cell lung cancer
early stage
end stage renal disease
epidermal growth factor receptor
spinal cord
tyrosine kinase
radiation therapy
newly diagnosed
locally advanced
chronic kidney disease
radiation induced
prognostic factors
peritoneal dialysis
patient reported outcomes